Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients

By Zamorano L.   Juan C.   Fernández-Olmos A.   Ge Y.   Cantón R.   Oliver A.  

Clinical Microbiology & Infection, Vol. 16, Iss. 9, 2010-09 ,pp. : 1482-1487

Blackwell Publishing

Access to resources Recommend Favorite

Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis

By Rougeron A.   Giraud S.   Razafimandimby B.   Meis J. F.   Bouchara J.-P.   Klaassen C. H. W.  

Clinical Microbiology & Infection, Vol. 20, Iss. 4, 2014-04 ,pp. : 327-333

Blackwell Publishing

Access to resources Recommend Favorite

Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients

By Worlitzsch D.   Rintelen C.   Böhm K.   Wollschläger B.   Merkel N.   Borneff-Lipp M.   Döring G.  

Clinical Microbiology & Infection, Vol. 15, Iss. 5, 2009-05 ,pp. : 454-460

Blackwell Publishing

Access to resources Recommend Favorite

Cystic fibrosis: deciphering the complexity

By Cantón R.   del Campo R.  

Clinical Microbiology & Infection, Vol. 16, Iss. 7, 2010-07 ,pp. : 793-797

Blackwell Publishing

Access to resources Recommend Favorite

Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients

By de Vrankrijker A. M. M.   Brimicombe R. W.   Wolfs T. F. W.   Heijerman H. G. M.   van Mansfeld R.   van Berkhout F. T.   Willems R. J. L.   Bonten M. J. M.   van der Ent C. K.  

Clinical Microbiology & Infection, Vol. 17, Iss. 3, 2011-03 ,pp. : 382-385

Blackwell Publishing

Access to resources Recommend Favorite